These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27930409)

  • 1. Serum Amyloid A as a Surrogate Marker for Mucosal and Histologic Inflammation in Patients with Crohn's Disease.
    Yarur AJ; Quintero MA; Jain A; Czul F; Barkin JS; Abreu MT
    Inflamm Bowel Dis; 2017 Jan; 23(1):158-164. PubMed ID: 27930409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum amyloid A level correlated with endoscopic findings in patients with Crohn's disease-Possible biomarker for evaluating mucosal healing.
    Ishihara S; Tada Y; Kawashima K; Kataoka M; Sonoyama H; Yamashita N; Oka A; Kusunoki R; Fukuba N; Mishima Y; Oshima N; Moriyama I; Yuki T; Kinoshita Y
    Dig Liver Dis; 2018 Jun; 50(6):553-558. PubMed ID: 29311027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Mucosal Healing in Crohn's Disease Using Practical Clinical Indices with Regard to the Location of Active Disease.
    Bamba S; Tsujikawa T; Ban H; Imaeda H; Inatomi O; Nishida A; Sasaki M; Andoh A; Fujiyama Y
    Hepatogastroenterology; 2014 May; 61(131):689-96. PubMed ID: 26176058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial.
    Peyrin-Biroulet L; Reinisch W; Colombel JF; Mantzaris GJ; Kornbluth A; Diamond R; Rutgeerts P; Tang LK; Cornillie FJ; Sandborn WJ
    Gut; 2014 Jan; 63(1):88-95. PubMed ID: 23974954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Marker for Mucosal Healing in Patients with Crohn's Disease.
    de Bruyn M; Arijs I; De Hertogh G; Ferrante M; Van Assche G; Rutgeerts P; Vermeire S; Opdenakker G
    J Crohns Colitis; 2015 Dec; 9(12):1079-87. PubMed ID: 26351381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of clinical and inflammatory markers with small bowel capsule endoscopy findings in Crohn's disease.
    Mitselos IV; Katsanos KH; Tatsioni A; Skamnelos A; Eliakim R; Tsianos EV; Christodoulou DK
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):861-867. PubMed ID: 29697457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein.
    Takeyama H; Mizushima T; Iijima H; Shinichiro S; Uemura M; Nishimura J; Hata T; Takemasa I; Yamamoto H; Doki Y; Mori M
    Dig Dis Sci; 2015 Nov; 60(11):3418-23. PubMed ID: 26077975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between serum adalimumab concentrations and endoscopic disease activity in patients with Crohn's disease.
    Morita Y; Imaeda H; Nishida A; Inatomi O; Bamba S; Sasaki M; Tsujikawa T; Sugimoto M; Andoh A
    J Gastroenterol Hepatol; 2016 Nov; 31(11):1831-1836. PubMed ID: 27043158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease Phenotype, Activity and Clinical Course Prediction Based on C-Reactive Protein Levels at Diagnosis in Patients with Crohn's Disease: Results from the CONNECT Study.
    Kwon JH; Im JP; Ye BD; Cheon JH; Jang HJ; Lee KM; Kim YS; Kim SW; Kim YH; Song GA; Han DS; Kim WH; Kim JS
    Gut Liver; 2016 Jul; 10(4):595-603. PubMed ID: 27021506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
    Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
    Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum amyloid A for predicting prognosis in patients with newly diagnosed Crohn's disease.
    Chen Q; Zhang X; Tie Y; Zhang J; Huang P; Xie Y; Zhang L; Tang X; Zeng Z; Li L; Chen M; Chen R; Zhang S
    BMJ Open Gastroenterol; 2024 Sep; 11(1):. PubMed ID: 39266020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal Calprotectin Levels Are Closely Correlated with the Absence of Relevant Mucosal Lesions in Postoperative Crohn's Disease.
    Garcia-Planella E; Mañosa M; Cabré E; Marín L; Gordillo J; Zabana Y; Boix J; Sáinz S; Domènech E
    Inflamm Bowel Dis; 2016 Dec; 22(12):2879-2885. PubMed ID: 27824646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin.
    Zubin G; Peter L
    Inflamm Bowel Dis; 2015 Jun; 21(6):1386-91. PubMed ID: 25851564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections.
    Çakan M; Aktay Ayaz N; Keskindemirci G; Karadağ ŞG; Tanatar A; Sönmez HE
    Clin Rheumatol; 2020 Jan; 39(1):249-253. PubMed ID: 31485845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Albumin and C-Reactive Protein/Albumin Ratio Are Useful Biomarkers of Crohn's Disease Activity.
    Qin G; Tu J; Liu L; Luo L; Wu J; Tao L; Zhang C; Geng X; Chen X; Ai X; Shen B; Pan W
    Med Sci Monit; 2016 Nov; 22():4393-4400. PubMed ID: 27848931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Amyloid A as an Early Marker of Infectious Complications after Laparoscopic Surgery for Colorectal Cancer.
    Wierdak M; Pisarska M; Kuśnierz-Cabala B; Witowski J; Major P; Ceranowicz P; Budzyński A; Pędziwiatr M
    Surg Infect (Larchmt); 2018; 19(6):622-628. PubMed ID: 30004836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein/abumin ratio is a useful biomarker for predicting the mucosal healing in the Crohn disease: A retrospective study.
    Zhou FS; Gao N; Sun X; Jiang XY; Chen JJ; Mao QQ; Zhong L
    Medicine (Baltimore); 2021 Mar; 100(10):e24925. PubMed ID: 33725853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of Neutrophil CD64 Blood Biomarkers to Detect Mucosal Inflammation in Pediatric Crohn's Disease.
    Minar P; Jackson K; Tsai YT; Sucharew H; Rosen MJ; Denson LA
    Inflamm Bowel Dis; 2017 Dec; 24(1):198-208. PubMed ID: 29272485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.
    Voiosu T; Benguş A; Dinu R; Voiosu AM; Bălănescu P; Băicuş C; Diculescu M; Voiosu R; Mateescu B
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):273-8. PubMed ID: 25267955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.